Living with metabolic dysfunction-associated steatotic liver disease (MASLD) often involves managing excess fat in the liver and improving how the body handles insulin. Recent research looks at how specific eating patterns, like ketogenic diets and intermittent fasting, might help patients manage these issues. Both approaches have shown potential to reduce body weight, improve insulin sensitivity, and decrease the amount of fat in the liver for some patients.
While these results are promising, the evidence comes with important notes. Most of the human data is short-term and depends heavily on the specific plan followed. Additionally, while some laboratory studies suggest that certain compounds in the body might help with inflammation, these effects have not been confirmed in human patients yet. There is also very little direct evidence showing that these diets can repair the gut barrier.
Because of these gaps, doctors suggest that these diets should not be used alone. They should be part of a complete care plan that considers a patient's specific risks, nutritional needs, and other health conditions. Patients should always work with a healthcare provider to determine if these dietary changes are safe and appropriate for their specific situation.
